The stepwise regression analysis demonstrated that the combination of clinical and laboratory parameters, including AST, ALT, amylase, and tumour markers like CA 19-9, provided a strong predictive model for CRP levels in patients with chronic cholecystitis. The gene discussed is GPT; the disease is neoplasm.